NCT05641935View on ClinicalTrials.gov

Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablation

PHASE2RecruitingINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

November 3, 2022

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions
Recurrent Renal Cell CarcinomaRenal Cell Carcinoma
Interventions
DRUG

Sulfur Hexafluoride Lipid Microspheres

Given IV

PROCEDURE

Contrast-Enhanced Ultrasound

Undergo CEUS

PROCEDURE

Computed Tomography

Undergo CT

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

OTHER

Electronic Health Record Review

Review electronic medical record

Trial Locations (1)

19107

RECRUITING

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

john eisenbrey

OTHER